About this trial
Obstructive sleep apnoea is the most common sleep disorder in general population, and is often associated with cognitive deficit, mood disorders, hypertension, diabetes mellitus, excessive daytime somnolence, nicturia and an increased cardiovascular and metabolic risk. The gold standard of treatment is Continuous Positive Airway Pressure (CPAP), but the adherence is often poor. The aim of our study is to investigate the effort based-decision making in patients with OSA, pre and post CPAP treatment, as a possible cause of poor adherence.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age ≥ 18
AHI±15
Disqualifiers
BMI ≥ 35 Kg/m2
MMSE <24
Complex sleep apnoea
Sleep disorder
Trial design
Parallel
Treatments tested in this trial
Continuous Positive Airway Pressure (CPAP) treatment
DeviceTreatment of Obstructive sleep apnoea syndrome with CPAP
Treatment groups
Trial outcomes
Primary outcomes
Memory
Short and Long-term memory will be assessed with Digit span and California verbal learning test
Executive Function
attentional and executive functioning will be assessed with Test of Attentional Performance (TAP)
Planning
Planning will be assessed with Tower of London
Response inhibition
Will be assessed with Test Go-nogo
Secondary outcomes
Effect of CPAP treatment on memory
Administration of Digit span and California verbal Learning test
Effect of CPAP treatment on executive function
Administration of Test attentional Performance
Effect of CPAP on planning
Adimnistration of Tower of London Test
Effect of CPAP on Response inhibition
administration of go no go Test
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Istituti Clinici Scientifici Maugeri SpA
Lead sponsor
Istituto Universitario di Studi Superiori Pavia
Collaborator